Compare Exenatide (evidence A) and Liraglutide (evidence A) on mechanism, clinical status, safety, and dosing.
Exenatide is a 39-amino-acid GLP-1 receptor agonist (MW ~4186.6 g/mol) originally derived from exendin-4, a peptide found in the saliva of the Gila monster…
Liraglutide is an FDA-approved GLP-1 receptor agonist with 97% amino acid sequence homology to endogenous human GLP-1. Developed by Novo Nordisk, it is…
Full profiles: Exenatide, Liraglutide.